Stock PLSE PULSE BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Pulse Biosciences, Inc.

Equities

PLSE

US74587B1017

Real-time Estimate Cboe BZX
Other stock markets
 03:29:46 2024-06-04 pm EDT 		5-day change 1st Jan Change
14.24 USD +4.82% Intraday chart for Pulse Biosciences, Inc. +7.88% +17.40%
May. 20 Pulse Biosciences Moves New Record Date for Rights Offering MT
May. 14 Pulse Biosciences Appoints Burke Barrett as President, CEO MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Pulse Biosciences Moves New Record Date for Rights Offering
MT
Pulse Biosciences Announces Updated Timing of Rights Offering for Up to $60,000,000
BU
PULSE BIOSCIENCES CELLFX NANOSECOND PULSED FIELD ABLATION TECHNOLOGY TO BE FEATURED IN SEVERAL PRESENTATIONS AT THE HEART RHYTHM SOCIETY 2024 ANNUAL MEETING
AQ
Pulse Biosciences’ CellFX Nanosecond Pulsed Field Ablation (nsPFA™) Technology to be Featured in Several Presentations at The Heart Rhythm Society 2024 Annual Meeting
BU
Pulse Biosciences Appoints Burke Barrett as President, CEO
MT
Pulse Biosciences Enhances Executive Leadership Team
BU
Pulse Biosciences, Inc Announces CEO Changes
CI
Pulse Biosciences, Inc Announces Executive Changes
CI
Pulse Biosciences Announces First U.S. Procedure with the CellFX nsPFA Percutaneous Electrode System
BU
Pulse Biosciences, Inc. Announces First U.S. Procedure with the CellFX nsPFA Percutaneous Electrode System
CI
Transcript : Pulse Biosciences, Inc., Q1 2024 Earnings Call, May 07, 2024
Pulse Biosciences Reports Business Updates and First Quarter 2024 Financial Results
BU
Pulse Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Pulse Biosciences Announces Timing of Rights Offering for Up to $60,000,000
BU
Pulse Biosciences Schedules First Quarter 2024 Financial Results Conference Call for May 7, 2024
BU
Sector Update: Health Care Stocks Slide Late Afternoon
MT
Pulse Biosciences Shares Fall After Q4 Results, Rights Issue Plans
MT
Transcript : Pulse Biosciences, Inc., Q4 2023 Earnings Call, Mar 28, 2024
Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2023 Financial Results
BU
Pulse Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PLSE Stock
  4. News Pulse Biosciences, Inc.